Results from Silverman et al 20 suggested that patients with osteoporosis did not have a significant preference for daily over weekly dosing, and also showed a trend toward monthly dosing being less preferred than weekly or daily dosing.
← all excerpts
Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK.
1
—
—